Cargando…
Rejection of immunogenic tumor clones is limited by clonal fraction
Tumors often co-exist with T cells that recognize somatically mutated peptides presented by cancer cells on major histocompatibility complex I (MHC-I). However, it is unknown why the immune system fails to eliminate immune-recognizable neoplasms before they manifest as frank disease. To understand t...
Autores principales: | Gejman, Ron S, Chang, Aaron Y, Jones, Heather F, DiKun, Krysta, Hakimi, Abraham Ari, Schietinger, Andrea, Scheinberg, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269121/ https://www.ncbi.nlm.nih.gov/pubmed/30499773 http://dx.doi.org/10.7554/eLife.41090 |
Ejemplares similares
-
Cloning, Clones and Clonal Disease
por: Luzzatto, Lucio
Publicado: (2000) -
B Tracks in Signal Events Rejected by the Level-1 Trigger
por: Legger, F, et al.
Publicado: (2004) -
Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking
por: Cheng, Shuhua, et al.
Publicado: (2021) -
Cell migration leads to spatially distinct but clonally related airway cancer precursors
por: Pipinikas, Christodoulos P, et al.
Publicado: (2014) -
Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies
por: Wild, Sophia A, et al.
Publicado: (2022)